C16ORF62 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.818800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.267600E-02
Normal-vs-Stage2
3.150000E-01
Normal-vs-Stage3
6.458300E-02
Normal-vs-Stage4
5.291200E-01
Stage1-vs-Stage2
4.491800E-01
Stage1-vs-Stage3
3.089400E-01
Stage1-vs-Stage4
6.376200E-01
Stage2-vs-Stage3
8.762400E-02
Stage2-vs-Stage4
9.923800E-01
Stage3-vs-Stage4
3.353600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.386600E-01
Normal-vs-AfricanAmerican
9.461000E-01
Normal-vs-Asian
2.064800E-01
Caucasian-vs-AfricanAmerican
1.191640E-01
Caucasian-vs-Asian
4.096000E-01
AfricanAmerican-vs-Asian
1.134420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.350400E-01
Normal-vs-Female
3.658000E-01
Male-vs-Female
1.419440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.421000E-01
Normal-vs-Age(41-60Yrs)
5.814800E-01
Normal-vs-Age(61-80Yrs)
2.006800E-01
Normal-vs-Age(81-100Yrs)
9.717700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.537200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.839000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.907400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.176200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.180500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.691600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.058220E-01
Normal-vs-Daily Drinker
9.069800E-02
Normal-vs-Weekly Drinker
9.286000E-02
Normal-vs-Occasional Drinker
4.219200E-01
Normal-vs-Social Drinker
4.325800E-01
Non Drinker-vs-Daily Drinker
7.532400E-01
Non Drinker-vs-Weekly Drinker
9.067800E-01
Non Drinker-vs-Occasional Drinker
7.235700E-02
Non Drinker-vs-Social Drinker
2.304200E-01
Daily Drinker-vs-Weekly Drinker
7.030000E-01
Daily Drinker-vs-Occasional Drinker
5.111600E-02
Daily Drinker-vs-Social Drinker
1.778610E-01
Weekly Drinker-vs-Occasional Drinker
1.287410E-01
Weekly Drinker-vs-Social Drinker
3.421400E-01
Occasional Drinker-vs-Social Drinker
7.409800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.171000E-01
Normal-vs-Grade 2
1.745990E-01
Normal-vs-Grade 3
2.234400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.098400E-01
Grade 1-vs-Grade 3
4.336600E-01
Grade 1-vs-Grade 4
3.171000E-01
Grade 2-vs-Grade 3
7.209600E-01
Grade 2-vs-Grade 4
1.745990E-01
Grade 3-vs-Grade 4
2.234400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.006000E-01
Normal-vs-NonDiabetic
2.231200E-01
Diabetic-vs-NonDiabetic
8.046800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.162800E-01
Normal-vs-NoPancreatitis
2.280400E-01
Pancreatitis-vs-NoPancreatitis
9.426200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.966780E-01
Normal-vs-N1
3.498400E-01
N0-vs-N1
1.487600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.815400E-01
Normal-vs-TP53-NonMutant
1.819350E-01
TP53-Mutant-vs-TP53-NonMutant
2.741400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
